Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ginkgo Bioworks Hldgs Inc (DNA)

Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,058,804
  • Shares Outstanding, K 2,211,278
  • Annual Sales, $ 251,460 K
  • Annual Income, $ -892,870 K
  • 60-Month Beta 1.06
  • Price/Sales 1.38
  • Price/Cash Flow N/A
  • Price/Book 0.39
Trade DNA with:

Options Overview Details

View History
  • Implied Volatility 96.84% ( -5.50%)
  • Historical Volatility 128.51%
  • IV Percentile 48%
  • IV Rank 15.76%
  • IV High 354.68% on 08/19/24
  • IV Low 48.61% on 03/27/24
  • Put/Call Vol Ratio 0.38
  • Today's Volume 2,689
  • Volume Avg (30-Day) 2,519
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 252,643
  • Open Int (30-Day) 246,212

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -2.80
  • Number of Estimates 2
  • High Estimate -2.40
  • Low Estimate -3.20
  • Prior Year -3.60
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.26 +40.87%
on 09/10/24
9.40 -21.17%
on 08/19/24
-1.45 (-16.37%)
since 08/16/24
3-Month
5.26 +40.87%
on 09/10/24
18.40 -59.73%
on 06/21/24
-9.43 (-56.00%)
since 06/18/24
52-Week
5.26 +40.87%
on 09/10/24
82.80 -91.05%
on 09/27/23
-66.59 (-89.99%)
since 09/18/23

Most Recent Stories

More News
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today

The company is forging ahead with next-generation drug development solutions.

GOOGL : 159.81 (+0.31%)
GOOG : 160.81 (+0.33%)
DNA : 7.41 (+8.81%)
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?

Could this beaten-down stock turn things around in the near future?

MRK : 118.64 (+0.30%)
NVO : 132.06 (+0.05%)
GOOGL : 159.81 (+0.31%)
GOOG : 160.81 (+0.33%)
DNA : 7.41 (+8.81%)
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock

The risks may resolve in a year or so but seizing the opportunities will take longer.

DNA : 7.41 (+8.81%)
This 1 AI Stock Could Revolutionize Biotech and Pharma

The company is using artificial intelligence, and planning to help others use AI empowered by its data collection.

DNA : 7.41 (+8.81%)
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?

Its ambitious business model may not be sustainable.

DNA : 7.41 (+8.81%)
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?

Have shares of the troubled life sciences business fallen too far?

DNA : 7.41 (+8.81%)
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks

Efficiency in core processes is set to increase substantially due to AI.

RXRX : 6.91 (+2.22%)
DNA : 7.41 (+8.81%)
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?

A recovery plan is underway, but it isn't a slam dunk.

DNA : 7.41 (+8.81%)
Why Ginkgo Bioworks Stock Is Sinking Today

There was double trouble for this beaten-down biotech stock.

DNA : 7.41 (+8.81%)
ARKK : 46.18 (+0.26%)
ARKG : 26.23 (-0.23%)
Bull Market and Beyond: 3 Stocks Just Waiting to Soar

These pharma and biotech players could become long-term winners.

SNY : 57.47 (+0.98%)
NVAX : 12.56 (-2.86%)
PFE : 29.75 (-0.27%)
DNA : 7.41 (+8.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 8.86
2nd Resistance Point 8.33
1st Resistance Point 7.87
Last Price 7.41
1st Support Level 6.88
2nd Support Level 6.35
3rd Support Level 5.89

See More

52-Week High 82.80
Fibonacci 61.8% 53.18
Fibonacci 50% 44.03
Fibonacci 38.2% 34.88
Last Price 7.41
52-Week Low 5.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar